LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
10.18632/oncotarget.25835
Saved in:
Main Authors: | Hee, Y.T, Yan, J, Nizetic, D, Chng, W.-J |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178073 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
BIOINFORMATICS ANALYSIS OF CYCLIN-DEPENDENT KINASE 5: INSIGHTS TO DRUG DISCOVERY
by: KOSARAJU VAMSI KRISHNA
Published: (2014) -
Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA
by: Tan, V.B.C., et al.
Published: (2014) -
p27 is regulated independently of Skp2 in the absence of Cdk2
by: Kaldis, Philipp, et al.
Published: (2016) -
Influences of phosphorylation on Thr14/Tyr15 in CDK5 in the presence of roscovitine/ATP and HHASPRK
by: Jin, H.-X., et al.
Published: (2014) -
CDK regulates septin organization through cell-cycle-dependent phosphorylation of the Nim1-related kinase Gin4
by: Li, C.-R., et al.
Published: (2014)